Cencora earnings were $1.9B for the trailing 12 months ending Jun 30, 2025, with 5.4% growth year over year. The latest COR earnings report on Jun 30, 2025 announced Q2 2025 earnings of $687.4M, down 4.2% from last quarter. For the last reported fiscal year 2024 ending Sep 30, 2024, COR reported annual earnings of $1.5B, with -13.5% growth.
COR past earnings growth
How has COR's earnings growth performed historically?
On COR's earnings call on Invalid Date, Cencora (NYSE: COR) reported Q2 2025 earnings per share (EPS) of $3.55, up 45.49% year over year. Total COR earnings for the quarter were $687.40 million. In the same quarter last year, Cencora's earnings per share (EPS) was $2.44.
As of the last Cencora earnings report, Cencora is currently profitable. Cencora's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $1.90 billion, a 2.21% increase year over year.
What was COR's earnings growth in the past year?
As of Cencora's earnings date in Invalid Date, Cencora's earnings has grown 5.37% year over year. This is 18.73 percentage points lower than the US Medical Distribution industry earnings growth rate of 24.1%. COR earnings in the past year totalled $1.90 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.